KALEIDO BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
| 2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index | CI |
| 2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index | CI |
Chart calendar Kaleido Biosciences, Inc.
d114c7ada697fb515de185cf7.eBfh2FBPuCHg6paco1B6Cz5knrvUikDAM97cm_yATNw.MWaZkigrjknVjbvd0iAxQVk37Y-F7SzzBrGOyL3zNOscIo2OHwvSd9Ok3w~804755774a9a9735a88b8eda4dbf479d
Upcoming events on Kaleido Biosciences, Inc.
No events available
Past events on Kaleido Biosciences, Inc.
| 20/01/2022 | Crohn’s and Colitis Congress |
| 19/01/2022 | Crohn and Colitis Congress - Abstract No. 3667985 |
| 22/11/2021 15:00 | Piper Sandler Virtual Healthcare Conference |
| 01/11/2021 11:30 | Q3 2021 Earnings Release |
| 19/10/2021 18:45 | Jefferies Next Generation IBD Therapeutics Summit |
| 05/10/2021 13:00 | R&D Day |
| 09/09/2021 19:45 | Morgan Stanley Global Healthcare Conference |
| 12/08/2021 19:30 | Canaccord Genuity Growth Conference |
| 10/08/2021 | Interim 2021 Earnings Release |
| 17/06/2021 21:00 | JMP Securities Life Sciences Conference |
| 13/06/2021 | Annual General Meeting |
| 04/05/2021 12:30 | Q1 2021 Earnings Release |
| 22/04/2021 13:00 | Jefferies Microbiome-based Therapeutics Summit |
| 24/03/2021 12:30 | KB109 Study Results Call |
| 08/03/2021 14:30 | Chardan Microbiome Medicines Summit |
| 03/03/2021 12:35 | FY 2020 Earnings Release |
| 20/01/2021 19:15 | Harnessing the Microbiome for Disease Prevention and Therapy Symposium |
| 14/01/2021 19:00 | JP Morgan Healthcare Conference |
| 30/11/2020 15:00 | Piper Sandler Health Care Conference - Pre-Recorded |
| 01/11/2020 | Q3 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 18,3 - | 0,98 12,2 -91.98% | 1,10 1,61 -31.26% |
|
EBITDA Million USD | Released Forecast Spread | -59,9 | -85,3 -68,1 -25.36% | -77,1 -58,7 -31.15% | -85,3 -91,7 6.92% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -86,7 -74,8 -15.79% | -78,9 -69,3 -13.87% | -87,7 -92,1 4.85% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -86,3 -89,3 3.32% | -81,6 -84,3 3.21% | -90,3 -93,6 3.54% |
|
Net income Million USD | Released Forecast Spread | -61,7 | -86,3 -89,1 3.11% | -81,6 -84,4 3.34% | -90,3 -93,8 3.7% |
|
EPS USD | Released Forecast Spread | -12,1 | -3,36 -3,45 2.5% | -2,44 -2,54 3.91% | -2,16 -2,24 3.56% |
| Announcement Date | 19/02/19 | 02/03/20 | 03/03/21 | 01/04/22 |
Quarterly results
| Fiscal Period | December | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 15,0 - | 0,00 0,00 - | 0,25 0,00 - | 0,48 0,00 - | 0,24 9,00 -97.3% | 0,30 0,00 - | 0,21 0,08 153.21% | 0,10 0,17 -38.82% | 0,49 1,12 -56.07% |
|
EBITDA Million USD | Released Forecast Spread | -18,6 -21,0 11.34% | -18,7 -19,0 1.66% | -21,9 -18,0 -21.82% | -18,7 -21,0 10.78% | -21,8 -23,0 5.34% | -22,6 -22,0 -2.84% | -21,8 -23,0 5.13% | -19,1 -24,0 20.44% | |
|
EBIT Million USD | Released Forecast Spread | -19,0 -22,4 15.38% | -19,1 -19,2 0.51% | -18,1 -19,6 7.28% | -22,4 -18,4 -21.33% | -19,3 -22,6 14.59% | -22,3 -26,2 14.56% | -23,2 -24,0 3.5% | -22,4 -24,0 6.71% | -19,7 -23,5 16.2% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,5 -22,4 12.85% | -19,6 -19,6 0.46% | -18,9 -19,5 3.16% | -23,1 -18,9 -22.2% | -20,0 -22,9 12.71% | -23,0 -23,8 3.18% | -23,9 -23,6 -1.2% | -23,1 -24,2 4.53% | -20,3 -23,6 14.08% |
|
Net income Million USD | Released Forecast Spread | -19,5 -22,4 12.85% | -19,6 -19,6 0.46% | -19,0 -19,5 2.8% | -23,1 -18,9 -22.2% | -20,0 -22,9 12.71% | -23,0 -23,8 3.18% | -23,9 -23,6 -1.2% | -23,1 -24,2 4.53% | -20,3 -23,6 14.08% |
|
EPS USD | Released Forecast Spread | -0,65 -0,73 11.35% | -0,64 -0,64 -0.43% | -0,59 -0,56 -6.31% | -0,65 -0,55 -18.82% | -0,56 -0,67 15.79% | -0,58 -0,57 -1.77% | -0,56 -0,57 1.17% | -0,54 -0,52 -3.11% | -0,48 -0,56 13.77% |
| Announcement Date | 02/03/20 | 14/05/20 | 04/08/20 | 02/11/20 | 03/03/21 | 04/05/21 | 11/08/21 | 01/11/21 | 01/04/22 |
More events
Past sector events for Kaleido Biosciences, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KLDO Stock
- Calendar Kaleido Biosciences, Inc.
